Indiana Hemophilia and Thrombosis Center

What Indiana Hemophilia and Thrombosis Center does

Indiana Hemophilia and Thrombosis Center (IHTC) operates as a wholly owned program of Innovative Hematology, Inc., a private non-profit founded in 1998 and headquartered at 8326 Naab Road in Indianapolis. The organization delivers specialized multidisciplinary care for a broad range of blood and bleeding disorders — including hemophilia A and B, von Willebrand disease (types 1, 2, and 3), thrombosis and clotting disorders, sickle cell disease, hereditary hemorrhagic telangiectasia (HHT), hemangiomas/vascular/lymphatic malformations (HVLM), immunohematology, and other rare bleeding disorders — serving patients from pediatric through adult life stages across Indiana.

The service platform is structured around a core Comprehensive Care program and supported by a set of specialty clinics (Joint Health, Sickle Cell Well, HVLM, HHT, and GO+ for adolescent transition), statewide Outreach Clinics, and a vertically integrated specialty pharmacy (Indiana BloodWoRx) holding URAC accreditation. Care delivery relies on an athenahealth-powered patient portal for scheduling, records access, and billing, alongside an in-house multidisciplinary team spanning physicians, nurse practitioners, physician assistants, physical therapists, pharmacists, psychologists, genetic counselors, social workers, dental hygienists, registered dietitians, and child life specialists.

The business model is that of a non-profit healthcare provider: clinical services are billed through insurance, Medicare, Medicaid, and patient self-pay, while the specialty pharmacy generates prescription revenue, and clinical research activity supplements operations through trial participation. Distribution is direct to patients via the Indianapolis main facility and Indiana outreach clinics, with no indication of out-of-state patient acquisition. Marketing leverages content (We Bleed Too podcast, blog), social media (Facebook, LinkedIn, Instagram, X, YouTube), and provider education programs. The organization holds AAAHC, ACHC, URAC Specialty Pharmacy, Anticoagulation Center of Excellence, WGBD Clinic of Excellence, and HHT-HTC designations, and is led by CEO & Medical Director Dr. Sanjay Ahuja (since April 1, 2026).

Name

Indiana Hemophilia and Thrombosis Center

Legal name

Innovative Hematology, Inc.

Website

https://ihtc.org

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

101–250 employees

Short description

Indiana Hemophilia and Thrombosis Center, a non-profit program of Innovative Hematology, Inc., provides multidisciplinary specialty care for hemophilia, sickle cell disease, HHT, and other blood disorders across Indiana via a main Indianapolis facility, statewide outreach clinics, specialty clinics, and a URAC-accredited specialty pharmacy.

Ownership category

akta.pro rank

Product category

Specialty Hematology Care

NAICS

Offices of Physicians (62111), Other Outpatient Care Centers (62149), All Other Outpatient Care Centers (621498), Other Ambulatory Health Care Services (6219)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Medical Hematology (Benign Hematology) (HLAKAFAA)

akta.pro secondary industries

Infusion Therapy Centers (Outpatient) (HLAFABAF), Hematology & Coagulation Laboratories (HLAFAMAC)

Keywords

• Hematology care services
• Bleeding disorder treatment
• Specialty pharmacy services
• Clinical research programs
• Multidisciplinary patient care

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Distribution channels3 records

Marketing channels4 records

Core offering

Indiana Hemophilia and Thrombosis Center provides comprehensive multidisciplinary hematology care for patients with hemophilia, von Willebrand disease, thrombosis, sickle cell disease, HHT, HVLM, and other rare bleeding disorders through its main Indianapolis facility and a network of Outreach Clinics across Indiana. The center operates specialized clinics including Joint Health, Sickle Cell Well, HVLM, HHT, and GO+ transition clinics, complemented by URAC-accredited specialty pharmacy services through Indiana BloodWoRx and clinical research programs offering access to advanced therapies.

Product overview

Innovative Hematology, Inc. operates the Indiana Hemophilia and Thrombosis Center (IHTC) as a comprehensive hematology care network offering a unified platform of specialized healthcare services. The core offering is Comprehensive Care for blood disorders including hemophilia, von Willebrand disease, thrombosis, sickle cell disease, HHT, and HVLM. This is supported by specialty pharmacy services through Indiana BloodWoRx and specialized clinics including Joint Health Clinic, Sickle Cell Well Clinic, HVLM Clinic, HHT Clinic, GO+ Clinic, and Outreach Clinics. Patient engagement is facilitated through an athenahealth-powered patient portal for appointments, health records, and bill payment. Educational outreach includes the We Bleed Too podcast for women's bleeding disorder awareness.

Differentiator

Problem solved

Functional benefit

Brands

• We Bleed Too: Video podcast series designed to make education on women's bleeding disorders more accessible

Products and services

• Comprehensive Care Program Core integrated treatment and management program for patients diagnosed with hemophilia A and B, von Willebrand disease, thrombosis, sickle cell disease, HHT, HVLM, immunohematological disorders, and other rare bleeding disorders. Care is delivered by a multidisciplinary team including hematologists, nurse practitioners, nurses, physical therapists, pharmacists, psychologists, genetic counselors, and social workers.
• Indiana BloodWoRx Specialty Pharmacy URAC-accredited specialty pharmacy providing specialized medication management, dispensing, and delivery services for patients with blood disorders served by IHTC.
• Joint Health Clinic Specialty clinic focused on preventing and treating joint damage and mobility issues common in hemophilia patients, delivered by physical therapists and hematology specialists.
• Sickle Cell Well Clinic Dedicated clinic providing comprehensive care, pain management, and wellness support for patients with sickle cell disease.
• HVLM Clinic Specialized clinic for Hemangioma, Vascular, and Lymphatic Malformations (HVLM) diagnosis, treatment, and ongoing management.
• HHT Clinic Dedicated clinic for Hereditary Hemorrhagic Telangiectasia (HHT) diagnosis, treatment, and ongoing multidisciplinary management of nosebleeds and arteriovenous malformations; designated as an HHT-HTC Treatment Center by HHT Foundation International.
• GO+ Clinic Specialized clinic providing comprehensive care and pediatric-to-adult transition services for adolescents and young adults with blood disorders.
• Outreach Clinics Network of satellite specialty clinics extending IHTC's specialized blood disorder care to patients across Indiana outside the Indianapolis metropolitan area.
• We Bleed Too Podcast Video podcast series designed to make education on women's bleeding disorders more accessible and reduce stigma; serves as a patient education and community engagement offering.

Segments8 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Partnerships

One partnership is on record.

• athenahealthcoreTechnology or IntegrationInnovative Hematology uses athenahealth's patient portal platform (Patient Portal ID: 25782) for appointment scheduling, bill payment, and electronic health record access. The portal is accessible at https://25782.portal.athenahealth.com/

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Mountain States Hemophilia & Thrombosis Center: Denver-based regional hemophilia and thrombosis treatment center offering comprehensive multidisciplinary care. Similar to IHTC as a non-academic regional specialty center with research and clinical programs.
• Cincinnati Children's Hospital - Hemophilia Treatment Center: Federally-recognized HTC delivering comprehensive pediatric and adult hemophilia care with research programs. Comparable in multidisciplinary model and clinical trial activity, though embedded within a larger pediatric academic medical center.
• Hemophilia Center of Western Pennsylvania: Regional hemophilia treatment center providing comprehensive blood disorder care. Directly comparable in scope, non-profit regional specialty model, and federally-recognized HTC designation.
• Bleeding & Clotting Disorders Institute: Independent, non-profit specialty center in Peoria, IL providing comprehensive hemophilia, thrombosis, and sickle cell care with multidisciplinary teams. The most direct operating peer to IHTC given similar non-profit specialty model and Midwest footprint.
• Children's Hospital of Philadelphia (CHOP) - Hematology: Major pediatric hematology program providing hemophilia, sickle cell, and rare bleeding disorder care with significant research infrastructure. Comparable in treating complex pediatric hematology patients, though at substantially larger scale within an academic system.
• Gulf States Hemophilia & Thrombophilia Center: Houston-based regional hemophilia treatment center with multidisciplinary hematology care and research. Comparable regional specialty model with similar patient population scope.

Broad incumbents

• Versiti: Major blood center and specialty diagnostics organization providing transfusion medicine, hematology research, and blood product services. Comparable in serving hematology patients across multiple states with an integrated blood/banking and clinical research capability.
• Children's Healthcare of Atlanta - Aflac Cancer & Blood Disorders Center: Large pediatric hematology program within a major children's hospital system, providing comprehensive sickle cell and hemophilia care with research. Comparable scope of services but at larger academic-institutional scale.

Others

• National Bleeding Disorders Foundation: National advocacy organization supporting the bleeding disorders community, including a network of HTCs. Not a direct competitor but a key ecosystem partner and patient referral pipeline for IHTC and similar centers.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/Indiana_HTC
• YouTubeyoutube.com/@InnovativeHematology/playlists
• Facebookfacebook.com/InnovativeHematology
• LinkedInlinkedin.com/company/innovative-hematology-inc
• Instagraminstagram.com/innovativehematology

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Indiana Hemophilia and Thrombosis Center